epiq Animal Health and KeraVet Bio have entered into a strategic partnership to market wound care animal product, KeraVet Gel
The partnership will work on supply chain solutions as well as aims at educating & training the animal health community. It benefits KeraVet Bio by offering one ship-to location along with inventory & account management, distribution partners by offering profitable products and veterinarians by offering access to essential products for the best possible care
KeraVet Gel, a reformulation of KeraStat Gel for humans, consists of a bitterant to reduce 85%+ licking. It is developed for faster wound healing ranging from surgical incisions to more complex, topical wound lesions in dogs and cats
Ref: Businesswire | Image: Zoetis
Related News:- Zoetis Reports Divestiture of its Medicated Feed Additive Portfolio to Phibro Animal Health
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
